An EU-funded, collaborative project aiming to develop a safe, prophylatic treatment of FNAIT
The drug that we will use to prevent FNAIT can only be made from plasma from women who have previously given birth to an FNAIT child.
Please sign up as plasma donor, if you have given birth to an FNAIT child and want to help us save the lives of babies at risk of developing FNAIT
Some excessive bleedings in foetuses and neonates occur because there are too few blood platelets to stop the bleeding. This may be caused by Foetal Neonatal Alloimmune Thrombocytopenia (FNAIT).
is an EU-funded collaborative project aiming to develop a safe new treatment that prevents excessive bleeding in foetuses and newborns caused by FNAIT.
Plasma from women who have had a foetus/child with FNAIT is needed to produce the new drug that can prevent FNAIT. We strongly encourage these women to donate plasma for production of this drug.
Don’t miss this recently published review article:www.ncbi.nlm.nih.gov/pubmed/26810319?dopt=Abstract ... See MoreSee Less
Fetal and neonatal alloimmune thrombocytopenia. - PubMed - NCBI
Semin Fetal Neonatal Med. 2016 Jan 19. pii: S1744-165X(15)00143-2. doi: 10.1016/j.siny.2015.12.004. [Epub ahead of print] REVIEW
2 weeks ago ·
For FNAIT awareness:www.ncbi.nlm.nih.gov/pubmed/26669518?dopt=Abstract ... See MoreSee Less
Old tools revisited give hope - new treatment option for families with a history of severe FNAIT...
Acta Obstet Gynecol Scand. 2015 Dec 15. doi: 10.1111/aogs.12842. [Epub ahead of print]
1 month ago ·
View on Facebook